Connect with us
Prague Gaming & TECH Summit 2024

Fintech PR

VitalHub Corp. Announces Closing of Bought Deal Offering

Published

on

Reading Time: 3 minutes

Toronto, Ontario–(Newsfile Corp. – March 17, 2020) – Vitalhub Corp. (TSXV: VHI) (the “Company” or “Vitalhub“) is pleased to announce it has closed its previously announced bought deal offering pursuant to a press release dated February 21, 2020. A total of 8,506,300 common shares of Vitalhub (the “Common Shares“) were sold at a price of $1.80 per Common Share for total gross proceeds of approximately $15.3 million (the “Offering“). The Offering was conducted by a syndicate of underwriters led by Cormark Securities Inc. and including Beacon Securities Limited and Canaccord Genuity Corp. (collectively, the “Underwriters“). The Offering included 1,006,300 Common Shares issued pursuant to the exercise of a portion of the over-allotment option granted to the Underwriters. The Common Shares were qualified for distribution by a short form prospectus in the provinces of Ontario, British Columbia and Alberta.

In connection with the Offering, the Company paid the Underwriters a cash commission of $839,363.40 and issued to the Underwriters 228,750 broker warrants (the “Broker Warrants“). Each Broker Warrant entitles the Underwriters to purchase a Common Share at an exercise price of $2.10 until March 17, 2022.

The net proceeds of the Offering will be used for growth initiatives, working capital and general corporate purposes. The Company’s growth initiative is focused on the acquisition of third-party enterprises in the health care industry which provide synergistic opportunities for the Company.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent registration under U.S. federal and state securities laws or an applicable exemption from such U.S. registration requirements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

ABOUT VITALHUB CORP.

VitalHub develops mission-critical technology solutions for Health and Human Services providers in the Mental Health (Child through Adult), Long Term Care, Community Health Service, Home Health, Social Service and Acute Care sectors. VitalHub technologies include Blockchain, Mobile, Patient Flow, Web-Based Assessment and Electronic Health Record solutions.

The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, VitalHub serves 200+ clients across North America. VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the TSX Venture Exchange under the symbol “VHI”.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release may constitute “forward-looking information” or “financial outlook” within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Corporation undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

CONTACT INFORMATION

Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53522

Fintech PR

Mintos expands its reach and officially debuts in France and the Netherlands

Published

on

mintos-expands-its-reach-and-officially-debuts-in-france-and-the-netherlands

BERLIN, March 19, 2024 /PRNewswire/ — Following its successful entrance in Germany, Italy and Spain, Mintos, the multi-asset platform offering a unique mix of alternative and traditional investment options, continues its European rollout by making its official debut in the French and Dutch investment markets. Since its founding in 2015, the platform has attracted over 500,000 users across Europe. Authorised by MiFID, the company currently manages over 600 million euros in assets under administration.

Investment Trends in France and the Netherlands

According to a recent survey conducted by AMF in France in collaboration with the European Union through the OECD*, nearly 1 in 4 French individuals report owning investments in financial instruments or crypto-assets. The survey reveals that new investors are primarily driven by the desire to diversify their savings, with 35% citing this as their primary reason for investing. An overwhelming 90% of investors believe that maintaining their investments over the long term will yield profitable returns.

In the ever-evolving landscape of investment, we want to emerge as the go-to platform for investors seeking sustained portfolio growth over time, prioritising stability over speculative gains.” comments Martins Sulte, CEO and co-founder of Mintos.

Similarly, Statistics Netherlands (CBS) and the Dutch Authority for the Financial Markets (AFM)** report that among the approximately 8.3 million private households in the Netherlands, approximately a quarter (totaling around 1.9 million), actively engage in investment activities.

“These findings underscore the widespread interest and participation in investment opportunities among Dutch households, reflecting a growing awareness of the importance of financial planning and wealth management” adds Martins Sulte.

Mintos offering: loans, Fractional Bonds and ETFs.

Mintos already holds a prominent position as the leading European platform for investing in loans, offering investors the opportunity to invest in consumer and small business credit for potentially attractive long-term returns.

Another recent addition to Mintos’ offerings is Fractional Bonds which allow customers to invest in high-yield bonds from as little as €50 and zero commissions and enjoy regular, fixed returns.

Mintos distinguishes itself by offering managed ETF portfolios with a minimum investment of €50 and completely free of charge, a significant advantage compared to other players in the market. These include bond and equity ETFs from renowned providers such as Amundi, iShares, JP Morgan, Vanguard, and others.

Investments in financial instruments are associated with risks.

* Source AMF France 

** Source dnb Netherland 

Media contact: email [email protected], contact number +49 1627383049

Logo –  https://mma.prnewswire.com/media/2244368/mintos_logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/mintos-expands-its-reach-and-officially-debuts-in-france-and-the-netherlands-302091840.html

Continue Reading

Fintech PR

Telkomsel and Huawei Inaugurate Indonesia’s First 5G Smart Warehouse and 5G Innovation Center

Published

on

telkomsel-and-huawei-inaugurate-indonesia’s-first-5g-smart-warehouse-and-5g-innovation-center

JAKARTA, Indonesia, March 19, 2024 /PRNewswire/ — Leading telecommunications provider Telkomsel and global ICT solutions provider Huawei have inaugurated Indonesia’s first 5G Smart Warehouse and 5G Innovation Center in Bekasi Regency, West Java. This landmark facility showcases the potential of 5G technology to transform warehouse management, boosting operational efficiency and creating new opportunities for the logistics industry to support the digital economy leapfrog towards the Golden Indonesia Vision 2045.

The inauguration ceremony was officiated by Mr. Long, CEO of Huawei Indonesia, and attended by dignitaries including Dr. Ir. Ismail MT, Director General of Resources Management and Equipment of Posts and Informatics, Ministry of Communication and Informatics; Indra Mardiatna, Telkomsel Director of Network; Derrick Heng, Telkomsel Marketing Director; Mahendra Rianto, Chairman of the Indonesian Logistics Association; and representatives from Bandung Institute of Technology, Telkom University, and other representatives from industry partners.

Director General Dr. Ir. Ismail MT emphasized, “Huawei’s 5G Smart Warehouse stands as both a wake-up call and a quintessential model for the ecosystem, demonstrating the immediate and seamless integration of 5G technology into digitalization efforts. This integration evidently yields innovative solutions that extend benefits beyond the logistics sector to a multitude of industries. Such advancements are attainable solely through the concerted efforts of all stakeholders, united in the pursuit of accelerating the nation’s digital transformation.”

Mr. Long, CEO of Huawei Indonesia, highlighted Huawei’s commitment to supporting the government and industry players to unlock Indonesia’s digital opportunities. “At last year’s Solo 5G summit, together with industry partners, we pledged to boost the 5G ecosystem. The 5G Smart Warehouse is a testament to the value that 5G technology can bring to traditional industries in Indonesia,” he stated.

Indra Mardiatna, Telkomsel Director of Network remarked, “Aligned with Indonesia’s vision of pioneering innovations that propel the nation’s advancement, Telkomsel remains steadfast in its commitment to deliver superior connectivity, pioneering solutions, and inventive services designed to foster empowerment and catalyze expansive opportunities for entrepreneurial growth within the country. We are optimistic that the deployment of the 5G Smart Warehouse alongside the 5G Innovation Center’s conceptual solutions will inaugurate a transformative era for professionals within the logistics sector, particularly by enhancing managerial competencies and amplifying the operational efficacy of warehousing systems. With the unwavering support of the government, courtesy of the Ministry of Communication and Information, and through synergistic partnerships with stakeholders including Huawei, industry associations, and the academic community, Telkomsel pledges to persist in championing the rapid evolution of Indonesia’s digital commerce and economic landscape, with a focus on inclusive and sustainable progress”

The digital economy, which is expected to be a major catalyst for Indonesia’s economy in the future, requires the backing of an efficient and effective logistics industry. Based on data from the Ministry of National Development Planning/Bappenas, Indonesia’s logistics costs have decreased from 23.5% to 14.29% of gross domestic product by 2023.

Benefits of the 5G Smart Warehouse 

Indonesia's first 5G Smart Warehouse

The 5G Smart Warehouse leverages advanced technologies like IoT and big data analytics to streamline operations, enhance safety and security, increase efficiency, and reduce energy consumptions and lower potential unexpected losses.

Warehouse managers can use digital twins and real-time data analysis to optimize inventory management and prevent stockouts.

The 5G network also facilitates swift and accurate communication between staff and autonomous guided vehicles (AGVs), ensuring efficient goods movement. Additionally, intelligent security systems powered by video and infrared sensors ensure warehouse safety.

Huawei’s 5G BTS technology powering the warehouse features an energy consumption of just 5 watts, equivalent to a single energy-saving light bulb, making it a sustainable solution for the future.

Photo – https://mma.prnewswire.com/media/2365771/Telkomsel_Huawei_inaugurating_Indonesia_s_5G_Smart_Warehouse_togther_partners.jpg

Photo – https://mma.prnewswire.com/media/2365772/Indonesia_s_5G_Smart_Warehouse.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/telkomsel-and-huawei-inaugurate-indonesias-first-5g-smart-warehouse-and-5g-innovation-center-302092422.html

Continue Reading

Fintech PR

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Published

on

cognizant-to-apply-generative-ai-to-enhance-drug-discovery-for-pharmaceutical-clients-with-nvidia-bionemo

Cognizant’s AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors

TEANECK, N.J., March 19, 2024 /PRNewswire/ — Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry, such as improving productivity in the development process and increasing the speed at which new, life-saving treatments can be brought to market.

Traditional drug discovery methodologies are process intensive and require the analysis of vast repositories of scientific literature and clinical data in order to reveal relevant insights. Moreover, traditional methods are burdened with high costs and long development lifecycles with a high rate of failure. By leveraging gen AI technologies, clinical researchers can rapidly sift through extensive datasets, more accurately predict interactions between drug compounds and create new, viable drug development pathways. 

“More than any other technological breakthrough in recent decades, generative AI has the potential to revolutionize the way new drugs are researched, developed and brought to market, making the creation of lifesaving discoveries faster, smarter and more accessible to all,” said Anna Elango, EVP, Cognizant’s Core Technologies & Insights. “By collaborating with NVIDIA, Cognizant can open the path to realizing this vision safely, responsibly and cost-effectively for our life sciences clients.”

By leveraging its deep life sciences and AI domain expertise and NVIDIA’s pretrained, industry-specific generative AI models offered as part of BioNeMo, Cognizant aims to give clients access to a suite of model-making services, including pretrained models, cutting-edge frameworks, and APIs, that offers clients the quickest path to train and customize enterprise models using their proprietary data. The offering is intended to enable this with reduced manual intervention for data analysis, and without the need to write elaborate code and build or maintain infrastructure.

“Generative AI will drive the next wave of enterprise productivity gains across industries, enabled by the NVIDIA AI Enterprise software platform,” said Alvin DaCosta, VP, Global Consulting Partner Organization, NVIDIA. “Using NVIDIA BioNeMo, Cognizant will help provide its life sciences clients with advanced, secure and reliable AI services to drive improved outcomes with custom drug discovery applications.”

Cognizant collaborates with leading global firms in pharmaceuticals, biotech and medical devices, covering the entire life sciences value chain from R&D to digital health. This work contributes to the industry’s ability to enhance science, improve patient outcomes, and increase business value, by enabling a patient-centric approach and better interactions with healthcare professionals. Cognizant’s life sciences offerings support more than 120 global manufacturing lines and more than 18 million patients with medical device company products. 

Cognizant intends to pursue additional applications by collaborating with NVIDIA in areas such as manufacturing and automotive engineering, where gen AI has the potential to enhance productivity, optimize costs and bring innovation to market more quickly. Cognizant intends to establish an NVIDIA AI Center of Excellence this year to further innovate with NVIDIA technologies, including the NVIDIA Metropolis, NVIDIA Omniverse and NVIDIA AI Enterprise platforms, for the benefit of clients across industries around the world.

About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we’re improving everyday life. See how at www.cognizant.com or @cognizant.

For more information, contact:

U.S.

Name Ben Gorelick

Email 
[email protected] 

Europe / APAC

Name Christina Schneider

Email
[email protected] 

India

Name Rashmi Vasisht

Email
[email protected] 

Logo – https://mma.prnewswire.com/media/1794711/Cognizant_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/cognizant-to-apply-generative-ai-to-enhance-drug-discovery-for-pharmaceutical-clients-with-nvidia-bionemo-302092233.html

Continue Reading

Trending